Acta Médica del Centro (Oct 2020)

High risk basal cell carcinoma, response to combined HeberFeron treatment and surface radiotherapy. Presentation of a case

  • Damarys Pérez Fleites,
  • Amelia Betancourt Pérez,
  • Yordan Martín Pozo

Journal volume & issue
Vol. 14, no. 4
pp. 569 – 575

Abstract

Read online

Introduction: basal cell carcinoma is a malignant tumor of cutaneous location and is the most frequent in humans, especially in the white race. When it appears in the periocular region it is considered to be of high risk due to the possibility of invasion into adjacent and underlying structures. Case presentation: male patient, skin phototype II, who came to the clinic because of the presence of a tumor lesion of 5X2.5cm in diameter, located in the left temple, involving the external angle of the eye. Clinical and histological diagnosis was made and treatment with HeberFeron was decided due to the location and size of the lesion. A first cycle of treatment was performed and a partial response was obtained with a reduction of the lesion to 2x2cm, and then a second cycle of treatment was decided. It was maintained as a stable disease, so treatment with superficial radiotherapy was indicated; it presented complete disease response, clinical and dermatoscopic. Conclusion: HeberFeron therapy was effective in reducing the lesion and, combined with superficial radiotherapy, achieved a complete clinical response and excellent aesthetic results.

Keywords